23.4 C
New York
Sunday, July 3, 2022

Guardion Health Sciences, Inc. (GHSI) Stock Outshining Premarket Despite Visible News.

Guardion Health Sciences, Inc. (GHSI) is one of the major providers of clinical nutritional products including medical foods, and dietary supplements. Its shares dipped slightly by 3.51% to be $0.21 during Tuesday’s regular trading. Its price rocketed higher as of the writing in the premarket session on April 6, by 41.6%. The one-year price range of its shares on the lower side is $0.16, while the higher side is $2.18 with a market cap of $12.06 million.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored


GHSI: Recent Developments

GHSI issued its fiscal year 2021 financial outcomes on April 1, for the full year 2021 ended on December 31, 2021. Some key highlights are stated below.

  • The total revenue of the company increased to $7.23 million as compared to $1.88 million for FY20. The company’s total revenue increased by 283% or $5.34 million over the year. The gain in revenue was attributed to its Viactiv product line.
  • Per-share basic and diluted net loss in fiscal 2021 was $24.7 million or $1.04 per share in comparison to a diluted net loss of $8.57 million or $0.60 per share. The company’s per-share net loss increased while its EPS decreased over the year and is majorly attributed to goodwill impairment.

GHSI: Industry Outlook

GHSI belongs to the personal products industry of the consumer staple sector. The analysts consider the consumer staple sector performs well in turbulent times acting as the investors’ safe harbor. The consumer staple sector was marked as defensive and it showed a downward stride of 1.1% for the prior quarter but outpaced market averages. The current confusing situation in Russia and Ukraine conflict is one of the major causes of the down performance of the sector.

Company Outlook

GHSI announced the closure of an $11 million public offering in February generating gross proceeds of up to $11.1 million along with launching Viactiv Omega BOOST Passion Fruit Flavored Gel Bites. Its Q1 2022 revenue is expected to be $2.21 million with -$0.08 EPS.

Conclusion

GHSI down performed in the last six months by more than 80% which indicates that the company should make a strong comeback. The recent premarket major rise is likely due to uncertainty as the company did not report any news of SEC filing.

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles

[class^="wpforms-"]
[class^="wpforms-"]